Eli Lilly’s Alzheimer’s Drug Kisunl...

By HEOR Staff Writer

September 30, 2024

Introduction Eli Lilly has achieved a milestone with its Alzheimer's drug Kisunla, recently approved by Japan's health ministry. Donanemab (Kisunla) is an antibody drug designe...
Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS...
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depres...
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Healthcare Needs of Sub-Saharan Africa’s Ageing Population
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
Caring for an Ageing US Population: Challenges and Innovations
Ensuring Ethical Medical Practice in the UAE with Guidelines
Enhancing HIV Testing Services Through Community Pharmacies in Nigeria